Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Neuroimmunology|February 16, 2000
Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitisT R Peters, D M Bodine, K T McDonagh, et al.
Arthritis and Rheumatism|August 16, 2000
Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four casesL J Crofford, J C Oates, W J McCune, et al.
Human Gene Therapy|July 1, 1994
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancerJ A O'Shaughnessy, K H Cowan, A W Nienhuis, et al.
International Journal of Cardiology|November 30, 2010
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFULC Ceconi, S B Freedman, J C Tardif, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 7, 2016
Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy studyClare J Taylor, Andrea K Roalfe, Rachel Iles, et al.
Investigational New Drugs|December 20, 2013
Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemiaKevin R Kelly, Thomas C Shea, André Goy, et al.
Investigational New Drugs|December 20, 2014
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemiasR Tibes, K T McDonagh, L Lekakis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Blood|August 15, 2002
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesPeter A McSweeney, Richard A Nash, Keith M Sullivan, et al.
Blood|April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyRichard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Pageof 7